Revolutionary Medical Device Earns FDA Recognition for SeaStar
SeaStar Medical secures its third FDA Breakthrough Device designation for the Selective Cytopheretic Device, promising hope for hepatorenal syndrome.
SeaStar Medical secures its third FDA Breakthrough Device designation for the Selective Cytopheretic Device, promising hope for hepatorenal syndrome.